RL
Richard S Levy (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $4.2M of MDGL (8,041 sh across 10 lots, as filed), executed Nov 13 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.8M
shares × price, as filed
Last traded
May 22
Filed May 22
Median ADV $194.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
MDGLRecent filings
MDGLSALE
Madrigal Pharmaceuticals, Inc.
View filing →
$2.8M5,371 sh across 8 lots
Exec May 22
Filed May 22 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $4.2M
8,041 sh across 10 lots
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $1.8M
5,000 sh × $350.00
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $1.4M
4,700 sh across 3 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET